Figure 2
From: Evaluation of adverse effects in tamoxifen exposed healthy female dogs
(A and B): Animal: A2 (intact, 0.5 mg/kg/day). (A) Cystic endometrial hyperplasia type I. Endometrial proliferation not associated with stromal inflammatory infiltration. HE, Obj. 20×. (B) Endometrial polyp formation. HE, Obj. 4×. (C and D): Animal: A4 (intact, 0.5 mg/kg/day). (C) Cystic endometrial hyperplasia type III with squamous metaplasia of endometrial cover epithelium and hemorrhage. HE, Obj. 20×. (D) Detail showing squamous metaplasia of endometrial cover epithelium and haemorrhage. HE, Obj. 60×.